US Stock MarketDetailed Quotes

CMND Clearmind Medicine

Watchlist

1.6600
-0.0100-0.60%

Close Jul 23 16:00 ET

1.5503
-0.1097-6.61%

Post 19:55 ET

5.50MMarket Cap-423P/E (TTM)

Clearmind Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Apr 30, 2024

(Q1)Jan 31, 2024

(FY)Oct 31, 2023

(Q4)Oct 31, 2023

(Q3)Jul 31, 2023

(Q2)Apr 30, 2023

(Q1)Jan 31, 2023

(FY)Oct 31, 2022

(Q4)Oct 31, 2022

(Q3)Jul 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-11.55%-1.19M

52.89%-1.46M

-66.50%-4.56M

-1,563.39%-370.91K

93.46%-12.98K

4.17%-1.07M

-121.63%-3.1M

-63.29%-2.74M

97.27%-22.3K

39.94%-198.35K

Net income from continuing operations

56.26%-908.22K

27.99%-1.37M

-23.04%-6.23M

-193.29%-2.8M

147.99%542.56K

-54.67%-2.08M

-15.93%-1.9M

-130.38%-5.07M

13.28%-954.8K

-30.86%-1.13M

Operating gains losses

-96.89%11.03K

-843.92%-41.67K

826.80%1.98M

--2.06M

---440.33K

--354.88K

--5.6K

--213.51K

----

Depreciation and amortization

15.87%15.74K

-60.76%8.63K

-31.87%41.59K

-92.86%1.23K

-85.94%4.78K

4,243.09%13.58K

131.15%21.99K

3,914.99%61.04K

1,032.78%17.22K

--33.99K

Deferred tax

-1,505.67%-130.26K

5,856.25%201.5K

-42.75%12.56K

-63.44%8.02K

---8.11K

--9.27K

--3.38K

--21.94K

--0

Other non cash items

461.38%1.63K

-99.96%1

-80.18%2.1K

-104.53%-91.0071

---488.9646

--290

--2.39K

--10.61K

--2.01K

----

Change In working capital

-109.59%-57.51K

80.43%-296.11K

-177.11%-700.7K

-42.02%320.64K

-124.84%-107.96K

2,230.28%599.6K

-2,875.35%-1.51M

5,814.15%908.72K

348.12%553.04K

-18.55%434.69K

-Change in receivables

-122.67%-21.49K

147.98%93.57K

-863.16%-111.81K

108.19%4.03K

-113.91%-15.64K

221.31%94.83K

-758.03%-195.03K

115.71%14.65K

-23.58%-49.26K

-55.78%112.44K

-Change in prepaid assets

-75.68%106.08K

59.65%-276.5K

-124.96%-18.9K

3,108.64%84.15K

1,229.03%145.98K

2,266.46%436.23K

-1,496.15%-685.26K

180.00%75.7K

97.04%-2.8K

--10.98K

-Change in payables and accrued expense

-8.51%-32.92K

58.35%-222.36K

-169.65%-570K

-61.58%232.46K

-176.56%-238.29K

-196.03%-30.34K

-311.99%-533.82K

302.65%818.37K

784.53%605.09K

11.39%311.26K

-Change in other working capital

----

210.42%109.18K

----

---98.88K

----

Cash from discontinued investing activities

Operating cash flow

-11.55%-1.19M

52.89%-1.46M

-66.50%-4.56M

-1,563.39%-370.91K

93.46%-12.98K

4.17%-1.07M

-121.63%-3.1M

-63.29%-2.74M

97.27%-22.3K

39.94%-198.35K

Investing cash flow

Cash flow from continuing investing activities

-363.97%-18.97K

-505.81%-24.76K

5.8K

97.25%-4.09K

97.09%-4.09K

Net PPE purchase and sale

----

--0

----

79.14%-4.09K

----

Net intangibles purchase and sale

----

--0

----

--0

----

Net other investing changes

----

---18.97K

---24.76K

----

Cash from discontinued investing activities

Investing cash flow

----

-363.97%-18.97K

-505.81%-24.76K

--5.8K

----

97.25%-4.09K

97.09%-4.09K

----

Financing cash flow

Cash flow from continuing financing activities

-95.07%145.13K

-16.25%5.32M

2,143.29%8.43M

4,106.05%1.45M

-3,020.50%-2.31M

505.42%2.94M

6.35M

-91.35%375.98K

97.66%-36.18K

-101.65%-73.89K

Net issuance payments of debt

15.88%-12.79K

60.09%-6.3K

43.18%-29.59K

108.64%1.28K

100.30%112.5193

---15.2K

---15.78K

---52.07K

---14.82K

---37.25K

Net common stock issuance

--0

-71.33%1.82M

1,777.63%8.04M

4,882.98%1.02M

-6,193.27%-2.31M

508.55%2.96M

--6.36M

-90.16%428.06K

98.62%-21.35K

-100.82%-36.64K

Proceeds from stock option exercised by employees

--157.92K

--3.5M

--426.68K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

-95.07%145.13K

-16.25%5.32M

2,143.29%8.43M

2,112.63%1.45M

-5,958.75%-2.31M

505.42%2.94M

--6.35M

-91.35%375.98K

95.34%-72.01K

-100.85%-38.06K

Net cash flow

Beginning cash position

175.60%9.29M

4,114.84%5.43M

-96.24%93.12K

875.13%2.9M

813.74%5.25M

52.89%3.37M

-96.43%128.78K

1,169.81%2.48M

-94.38%297.64K

-49.46%574.09K

Current changes in cash

-151.73%-969.15K

18.79%3.85M

263.18%3.86M

1,784.13%1.05M

-749.58%-2.31M

397.47%1.87M

331.73%3.24M

-193.69%-2.36M

97.50%-62.57K

-106.54%-272.24K

Effect of exchange rate changes

-464.36%-10.9K

188.14%3.72K

-63.93%-27.29K

-61.16%-27.27K

1,010.42%1.21K

521.60%2.99K

-1,234.23%-4.22K

---16.64K

---16.92K

--109.2729

End cash Position

58.34%8.31M

175.60%9.29M

4,047.73%3.92M

875.13%2.9M

813.74%5.25M

52.89%3.37M

-96.52%94.62K

-94.38%297.64K

Free cash flow

-11.55%-1.19M

52.89%-1.46M

-66.25%-4.56M

-1,305.70%-370.91K

93.46%-12.98K

4.17%-1.07M

-121.63%-3.1M

-51.20%-2.74M

97.21%-26.39K

39.92%-198.35K

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Apr 30, 2024	(Q1)Jan 31, 2024	(FY)Oct 31, 2023	(Q4)Oct 31, 2023	(Q3)Jul 31, 2023	(Q2)Apr 30, 2023	(Q1)Jan 31, 2023	(FY)Oct 31, 2022	(Q4)Oct 31, 2022	(Q3)Jul 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-11.55%-1.19M	52.89%-1.46M	-66.50%-4.56M	-1,563.39%-370.91K	93.46%-12.98K	4.17%-1.07M	-121.63%-3.1M	-63.29%-2.74M	97.27%-22.3K	39.94%-198.35K
Net income from continuing operations	56.26%-908.22K	27.99%-1.37M	-23.04%-6.23M	-193.29%-2.8M	147.99%542.56K	-54.67%-2.08M	-15.93%-1.9M	-130.38%-5.07M	13.28%-954.8K	-30.86%-1.13M
Operating gains losses	-96.89%11.03K	-843.92%-41.67K	826.80%1.98M	--2.06M	---440.33K	--354.88K	--5.6K	--213.51K	----	----
Depreciation and amortization	15.87%15.74K	-60.76%8.63K	-31.87%41.59K	-92.86%1.23K	-85.94%4.78K	4,243.09%13.58K	131.15%21.99K	3,914.99%61.04K	1,032.78%17.22K	--33.99K
Deferred tax	-1,505.67%-130.26K	5,856.25%201.5K	-42.75%12.56K	-63.44%8.02K	---8.11K	--9.27K	--3.38K	--21.94K	--21.94K	--0
Other non cash items	461.38%1.63K	-99.96%1	-80.18%2.1K	-104.53%-91.0071	---488.9646	--290	--2.39K	--10.61K	--2.01K	----
Change In working capital	-109.59%-57.51K	80.43%-296.11K	-177.11%-700.7K	-42.02%320.64K	-124.84%-107.96K	2,230.28%599.6K	-2,875.35%-1.51M	5,814.15%908.72K	348.12%553.04K	-18.55%434.69K
-Change in receivables	-122.67%-21.49K	147.98%93.57K	-863.16%-111.81K	108.19%4.03K	-113.91%-15.64K	221.31%94.83K	-758.03%-195.03K	115.71%14.65K	-23.58%-49.26K	-55.78%112.44K
-Change in prepaid assets	-75.68%106.08K	59.65%-276.5K	-124.96%-18.9K	3,108.64%84.15K	1,229.03%145.98K	2,266.46%436.23K	-1,496.15%-685.26K	180.00%75.7K	97.04%-2.8K	--10.98K
-Change in payables and accrued expense	-8.51%-32.92K	58.35%-222.36K	-169.65%-570K	-61.58%232.46K	-176.56%-238.29K	-196.03%-30.34K	-311.99%-533.82K	302.65%818.37K	784.53%605.09K	11.39%311.26K
-Change in other working capital	----	210.42%109.18K	----	----	----	----	---98.88K	----	----	----
Cash from discontinued investing activities
Operating cash flow	-11.55%-1.19M	52.89%-1.46M	-66.50%-4.56M	-1,563.39%-370.91K	93.46%-12.98K	4.17%-1.07M	-121.63%-3.1M	-63.29%-2.74M	97.27%-22.3K	39.94%-198.35K
Investing cash flow
Cash flow from continuing investing activities			-363.97%-18.97K	-505.81%-24.76K	5.8K			97.25%-4.09K	97.09%-4.09K
Net PPE purchase and sale	----	----	--0	----	----	----	----	79.14%-4.09K	----	----
Net intangibles purchase and sale	----	----	--0	----	----	----	----	--0	----	----
Net other investing changes	----	----	---18.97K	---24.76K	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	----	----	-363.97%-18.97K	-505.81%-24.76K	--5.8K	----	----	97.25%-4.09K	97.09%-4.09K	----
Financing cash flow
Cash flow from continuing financing activities	-95.07%145.13K	-16.25%5.32M	2,143.29%8.43M	4,106.05%1.45M	-3,020.50%-2.31M	505.42%2.94M	6.35M	-91.35%375.98K	97.66%-36.18K	-101.65%-73.89K
Net issuance payments of debt	15.88%-12.79K	60.09%-6.3K	43.18%-29.59K	108.64%1.28K	100.30%112.5193	---15.2K	---15.78K	---52.07K	---14.82K	---37.25K
Net common stock issuance	--0	-71.33%1.82M	1,777.63%8.04M	4,882.98%1.02M	-6,193.27%-2.31M	508.55%2.96M	--6.36M	-90.16%428.06K	98.62%-21.35K	-100.82%-36.64K
Proceeds from stock option exercised by employees	--157.92K	--3.5M	--426.68K	----	----	--0	--0	--0	----	----
Cash from discontinued financing activities
Financing cash flow	-95.07%145.13K	-16.25%5.32M	2,143.29%8.43M	2,112.63%1.45M	-5,958.75%-2.31M	505.42%2.94M	--6.35M	-91.35%375.98K	95.34%-72.01K	-100.85%-38.06K
Net cash flow
Beginning cash position	175.60%9.29M	4,114.84%5.43M	-96.24%93.12K	875.13%2.9M	813.74%5.25M	52.89%3.37M	-96.43%128.78K	1,169.81%2.48M	-94.38%297.64K	-49.46%574.09K
Current changes in cash	-151.73%-969.15K	18.79%3.85M	263.18%3.86M	1,784.13%1.05M	-749.58%-2.31M	397.47%1.87M	331.73%3.24M	-193.69%-2.36M	97.50%-62.57K	-106.54%-272.24K
Effect of exchange rate changes	-464.36%-10.9K	188.14%3.72K	-63.93%-27.29K	-61.16%-27.27K	1,010.42%1.21K	521.60%2.99K	-1,234.23%-4.22K	---16.64K	---16.92K	--109.2729
End cash Position	58.34%8.31M	175.60%9.29M	4,047.73%3.92M	4,047.73%3.92M	875.13%2.9M	813.74%5.25M	52.89%3.37M	-96.52%94.62K	-96.52%94.62K	-94.38%297.64K
Free cash flow	-11.55%-1.19M	52.89%-1.46M	-66.25%-4.56M	-1,305.70%-370.91K	93.46%-12.98K	4.17%-1.07M	-121.63%-3.1M	-51.20%-2.74M	97.21%-26.39K	39.92%-198.35K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall